Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dynavax Technologies
(NQ:
DVAX
)
11.55
-0.46 (-3.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dynavax Technologies
< Previous
1
2
3
4
5
Next >
Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
May 05, 2022
Via
Benzinga
Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
March 17, 2022
Via
Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
March 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Dynavax Technologies Q4 Earnings
February 28, 2022
Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
A Preview Of Dynavax Technologies's Earnings
February 25, 2022
Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows
January 19, 2022
Valneva SE (NASDAQ: VALN) has announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of Valneva's COVID-19 vaccine...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
December 29, 2021
Tigress Financial lifted the price target on McDonald's Corporation (NYSE:
Via
Benzinga
Here's Why These 3 COVID-19 Vaccine Stocks Got Crushed This Week
December 03, 2021
These second-tier COVID-19 vaccine players plunged due to fears about the potential impacts of the omicron variant.
Via
The Motley Fool
Exposures
COVID-19
Why Dynavax Stock Is Tumbling Today
December 03, 2021
The biotech stock is being pulled down by the broader market sell-off.
Via
The Motley Fool
Why Are Valneva Shares Trading Higher Today?
November 23, 2021
Valneva SE (NASDAQ: VALN) has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID...
Via
Benzinga
2 Top Stocks You Can Still Buy for Under $20 a Share
November 12, 2021
These two stocks have more than doubled in 2021, but they still can be bought for under $20 per share.
Via
The Motley Fool
Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
November 10, 2021
Valneva SE (NASDAQ: VALN) shares jumped more than 20% after winning approval from the European Commission for a deal. Over two years, the Company would supply up...
Via
Benzinga
Exposures
COVID-19
Why Dynavax Stock Is Falling Today
November 05, 2021
Shares of the vaccine maker are down sharply despite a positive earnings report.
Via
The Motley Fool
Dynavax Technologies (DVAX) Q3 2021 Earnings Call Transcript
November 05, 2021
DVAX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
92 Biggest Movers From Friday
November 08, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...
Via
Benzinga
64 Stocks Moving In Friday's Mid-Day Session
November 05, 2021
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
November 05, 2021
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough...
Via
Benzinga
Will Valneva and Dynavax Score With Their Late-to-the-Party COVID Vaccine?
October 29, 2021
There's still a sizable market opportunity, especially in developing nations.
Via
The Motley Fool
Exposures
COVID-19
Why Shares of Dynavax Technologies, Ocugen, and Valneva Are on the Move Today
October 18, 2021
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.
Via
The Motley Fool
Exposures
COVID-19
Why Are Valneva's Shares Trading Higher Monday Premarket?
October 18, 2021
Valneva SE's (NASDAQ: VALN) COVID-19 vaccine elicits a robust immune response with far fewer side effects than the Oxford/AstraZeneca plc's (NASDAQ: AZN) jab,...
Via
Benzinga
Exposures
COVID-19
21 Stocks Moving in Monday's Pre-Market Session
October 18, 2021
Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine...
Via
Benzinga
Exposures
COVID-19
Best Pharmaceutical Stocks To Buy In 2021
October 06, 2021
The global pharmaceutical market has experienced significant growth in recent years. As of end-2020, the total global pharmaceutical market was valued at about 1.27 trillion U.S. dollars.
Via
Talk Markets
54 Biggest Movers From Friday
October 04, 2021
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....
Via
Benzinga
Why Dynavax Technologies Stock Is Sliding Today
October 01, 2021
A possible oral COVID-19 treatment is weighing on the shares of vaccine markers like Dynavax today.
Via
The Motley Fool
Topics
Death
Exposures
COVID-19
Death
How Will Valneva's COVID Vaccine Setback Impact Dynavax?
September 25, 2021
It's definitely not a showstopper for the biotech or its CpG 1018 adjuvant.
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...
Via
Benzinga
Cramer Shares His Thoughts On Dynavax, Nucor And Amarin
September 24, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Dynavax Technologies Corporation (NASDAQ: DVAX) is good. He loves the immuno drug stories. Cramer said you are...
Via
Benzinga
DVAX Stock: What Is the Covid-19 News Lifting Dynavax Today?
September 22, 2021
Today, some impressive vaccine-related news has sent Dynavax and shares of DVAX stock significantly higher as investors pile in.
Via
InvestorPlace
Exposures
COVID-19
50 Biggest Movers From Yesterday
September 23, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.